MedImmune is integral to AstraZeneca's plans to establish a major global presence in biologics. Offering a modern working environment with recently expanded, state-of-the-art facilities, MedImmune in Cambridge (formerly known as Cambridge Antibody Technology or CAT) continues to expand its biopharmaceutical research and development capabilities.
We are an innovative and exciting place to work and, along with our colleagues in the U.S., are part of a world-leading biologics business.
To join part of this ambitious challenge, we are looking for enthusiastic, high-calibre individuals who can offer an innovative, driven and flexible approach.